| |
| |
|
| Insider
Information: |
Tang Capital Partners Lp |
| Relationship: |
10% Owner |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
15 |
|
| Direct
Shares |
123,746 |
|
|
Indirect Shares
|
35,438,120 |
|
|
| Direct
Value |
$25,042 |
|
|
|
Indirect Value
|
$71,622,161 |
|
|
| Total
Shares |
35,561,866 |
|
|
| Total
Value |
$71,647,202 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
14
|
1
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
11
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -4.3%
|
-74.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2006-06-14 |
4 |
B |
$3.52 |
$77,792 |
I/I |
22,100 |
801,405 |
1.5 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-05-09 |
4 |
B |
$1.80 |
$42,421 |
I/I |
23,575 |
4,688,713 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-02-23 |
4 |
B |
$1.42 |
$34,238 |
I/I |
24,140 |
5,575,336 |
1.5 |
- |
|
| RAIN |
Rain Therapeutics Inc. |
10% Owner |
– – • |
2023-12-14 |
4 |
S |
$1.21 |
$29,531 |
I/I |
(24,406) |
4,000,080 |
0 |
- |
|
| TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
– – • |
2008-02-15 |
4 |
S |
$0.09 |
$2,148 |
D/D |
(25,000) |
0 |
0 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-04-08 |
4 |
B |
$1.83 |
$45,750 |
I/I |
25,000 |
3,290,400 |
1.5 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-04-28 |
4 |
B |
$1.79 |
$44,750 |
I/I |
25,000 |
4,182,038 |
1.5 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-13 |
4 |
B |
$0.24 |
$6,000 |
I/I |
25,000 |
5,380,000 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-03-11 |
4 |
B |
$1.30 |
$33,890 |
I/I |
25,100 |
6,396,598 |
1.5 |
- |
|
| NTEC |
Neose Technologies Inc |
10% Owner |
– – • |
2008-09-26 |
4 |
B |
$0.33 |
$8,466 |
I/I |
25,763 |
10,403,842 |
1.5 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2010-01-12 |
4 |
S |
$10.88 |
$298,310 |
I/I |
(27,419) |
2,857,252 |
0 |
- |
|
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2007-01-04 |
4 |
B |
$4.33 |
$124,433 |
I/I |
28,732 |
1,609,861 |
1.5 |
- |
|
| HRTX |
Heron Therapeutics Inc |
10% Owner |
– – • |
2015-06-02 |
4 |
B |
$23.84 |
$772,294 |
I/I |
32,395 |
4,746,318 |
1.5 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-05-08 |
4 |
B |
$1.80 |
$59,830 |
I/I |
33,100 |
4,665,138 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-03-10 |
4 |
B |
$1.43 |
$50,050 |
I/I |
35,000 |
6,371,498 |
1.5 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2010-01-11 |
4 |
S |
$11.00 |
$392,641 |
I/I |
(35,681) |
2,884,671 |
0 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-04-18 |
4 |
B |
$1.80 |
$66,060 |
I/I |
36,700 |
3,802,038 |
1.5 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-05-14 |
4 |
B |
$1.80 |
$67,039 |
I/I |
37,300 |
4,757,038 |
1.5 |
- |
|
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2007-12-19 |
4 |
B |
$13.25 |
$499,936 |
I/I |
37,731 |
2,300,798 |
1.5 |
- |
|
| TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
– – • |
2023-05-11 |
4 |
B |
$1.95 |
$75,592 |
I/I |
38,765 |
4,338,617 |
1.5 |
% |
|
| RDEA |
Ardea Biosciences Inc |
10% Owner |
– – • |
2007-12-05 |
4 |
B |
$11.78 |
$459,330 |
I/I |
39,000 |
2,249,067 |
1.5 |
- |
|
| RAIN |
Rain Therapeutics Inc. |
10% Owner |
– – • |
2023-12-18 |
4 |
S |
$1.21 |
$48,560 |
I/I |
(40,132) |
3,850,513 |
0 |
- |
|
| NSTR |
Northstar Neuroscience In... |
10% Owner |
– – • |
2008-04-14 |
4 |
B |
$1.79 |
$74,611 |
I/I |
41,587 |
3,471,300 |
1.5 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2008-10-10 |
4 |
B |
$0.24 |
$10,602 |
I/I |
45,000 |
5,355,000 |
1.5 |
- |
|
| PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
– – • |
2009-02-19 |
4 |
B |
$1.47 |
$66,258 |
I/I |
45,000 |
5,551,196 |
1.5 |
- |
|
176 Records found
|
|
Page 3 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
